Top Markets
Coin of the day
Samsung Biologics Co.,Ltd. Samsung Biologics Co.,Ltd.

Samsung Biologics Co.,Ltd.

207940
Rankning i aktier #519
Samsung Biologics Co.,Ltd., established in 2011 and headquartered in Incheon,... Samsung Biologics Co.,Ltd., established in 2011 and headquartered in Incheon, South Korea, provides contract services for biopharmaceutical products. The company's operations are divided into two main segments: Contract Manufacturing Organization (CMO) and Contract Development Organization (CDO). Its CDO services cover areas such as cell line development, optimization of upstream and downstream processes, and the formulation of analytical methods and final products. For CMO, the company offers aseptic filling, lyophilization, finishing, storage, shipping, and various associated support services. Additionally, it delivers comprehensive quality assurance, quality control, biosafety, and analytical testing. Samsung Biologics is also involved in creating and launching biosimilar drugs, alongside manufacturing mammalian cell-based antibody medications.
Aktiekurs
$1,071.12
Marknadsvärde
$49.58B
Förändring (1 dag)
-3.73%
Förändring (1 år)
-5.56%
Land
KR
Handel Samsung Biologics Co.,Ltd. (207940)

Kategori

Aktiekurshistorik för Samsung Biologics Co.,Ltd. (207940)
Högsta slutkurs: $1.09K den 2026-08-01

Lägsta slutkurs: $215.60 den 2016-11-01
Aktiekurshistorik för Samsung Biologics Co.,Ltd. från 2016 till 2026
Årlig aktiekursutveckling
År Prestanda
2026 (TTM) -3.68%
2025 12.74%
2024 21.95%
2023 -14.64%
2022 -16.07%
2021 2.83%
2020 117.47%
2019 6.18%
2018 -1.56%
2017 164.22%
2016 0.00%
Aktiekurs för liknande företag eller konkurrenter
Företag Aktiekurs Förändring 1år% Land
$527.87 36.13%
US
$873.57 37.02%
NL
$736.38 8.73%
CH
$263.09 20.45%
BE
$97.64 -43.42%
AU